Objective: To measure the economic impact of conditionally essential amino acids (CEAA) among patients with operative treatment for fractures.
Methods: A decision tree model was created to estimate changes in annual health care costs and quality of life impact due to complications after patients underwent operative treatment to address a traumatic fracture. The intervention of interest was the use of CEAA alongside standard of care as compared to standard of care alone.